Drugs / immunoglobulin C
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT04664010 Background | Feb 2020 → Sep 2022 | COVID-19 | Xi'an International Medical Center Hospital | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | immunoglobulin C | “intravenous administration of 10 g immunoglobulin C, once a day, 3-5 days” NCT04664010 ↗ |
| Route | Intravenous | “intravenous administration of 10 g immunoglobulin C” NCT04664010 ↗ |